Late Life and Neurocognitive Disorders

Overview of Neurocognitive Disorders (NCDs)

  • Definition of NCDs: According to the DSM-V, Neurocognitive disorders (NCDs) are categorized as disorders in which the core features are primarily cognitive.
  • Cognitive Impairment as a Primary Diagnostic Feature: While cognitive deficits may manifest in other psychological or medical disorders, in NCDs, the impairment to cognition is the central and primary diagnostic feature.
  • Vulnerability: The elderly population is identified as the group most vulnerable to developing these types of disorders.

Myths and Realities of Aging

  • Common Perceptions and Myths: Older individuals are frequently and falsely perceived as being perpetually slow, confused, and easily agitated. There is a common belief that aging inevitably leads to becoming unhappy, dissatisfied, having difficulty coping with life’s problems, and being obsessively focused on poor health.
  • The Reality of Late Life: In truth, many of these negative perceptions are false. A majority of elderly people do not experience severe cognitive dysfunction.
  • Emotional Skill and Regulation: Elderly individuals are actually more skilled at conveying and regulating their emotions compared to younger populations.
  • Social Selectivity Theory: This concept posits that as we age, our priorities undergo a shift. Individuals move away from the desire to form new relationships and instead focus on cultivating and appreciating the meaningful relationships they already have, particularly those with close friends and family members.

Challenges and Problems in Later Life

  • General Vulnerability: The elderly may experience the most significant volume of problems—both physical and psychological—of any age group.
  • Physical and Sensory Challenges:     * Physical decline and disabilities.     * Sensory deficits (hearing, sight, etc.) and neurological deficits.     * Significant decline in the quality and depth of sleep.
  • Psychosocial Stressors:     * Loss of loved ones (bereavement).     * The cumulative effect of negative life experiences over a lifetime.     * Social stigmas directed toward their age group.
  • Health and Medication Risks:     * Chronic health problems tend to worsen over time rather than diminish.     * Complex interactions between multiple medications (polypharmacy).     * Psychoactive drugs are often designed for and tested on younger people, which may affect their efficacy or safety in older patients.

Major Neurocognitive Disorders (Dementia)

  • Principle Types of NCDs: Late-life NCDs generally fall into two categories: Dementia (deterioration of cognitive abilities) and Delirium (a state of mental confusion).
  • DSM-V Criteria for Major Neurocognitive Disorder:     * Evidence of significant cognitive decline from previous levels in one or more domains. This must be based on:         1. Concerns expressed by the patient, a clinician, or a close associate.         2. Substantial neurocognitive impairment, preferably documented via standardized neuropsychological testing or an equivalent clinical assessment.     * The cognitive deficits must interfere with the individual's independence and their ability to perform everyday activities.     * The deficits must not occur exclusively in the context of delirium.     * The deficits are not better explained by another psychological disorder.
  • Types of Dementia:     1. Alzheimer's disease.     2. Frontotemporal Dementia.     3. Vascular Dementia.     4. Dementia with Lewy Bodies.
  • Course of Dementia: Depending on the underlying cause, the course can be progressive, static, or remitting.
  • Prevalence Statistics:     * Worldwide prevalence: approximately 0.4%0.4 \%.     * Prevalence increases with age: 1–2%1 \text{--} 2 \% of people aged 60–69 years60 \text{--} 69 \, \text{years}.     * Prevalence reaches 20%20 \% for individuals aged 85 years85 \, \text{years} and older.
  • Common Symptoms:     * Difficulty remembering things.     * Confusion and impaired judgment.     * Lack of impulse control.     * Disturbances in emotion and affect.     * Language disturbances.

Alzheimer’s Disease (AD)

  • Nature of the Disease: AD is a progressive and irreversible deterioration of brain tissue that produces both cognitive and behavioral symptoms.
  • Mortality: It is the 7th7\text{th} leading cause of death for men and women aged 65 years65 \, \text{years} and older.
  • Progression: Characterized by a gradual decline in language skills, visual-spatial abilities, and memory.
  • Pathology:     * Marked increase in beta-amyloid plaques.     * Tau-predominant neurofibrillary tangles in the brain.     * Neuronal death and significant reduction in cortical tissue.
  • Brain Imaging (PET Scans): Positron Emission Tomography (PET) scans identify AD by showing reduced brain activity. Normal brains show high activity, while AD brains exhibit blue and black areas indicating significantly reduced activity.
  • Risk Factors:     * Advanced age.     * Genetic factors: Specifically the Apolipoprotein E-4 (APOE-4APOE\text{-}4) gene.     * Smoking and mood disorders (e.g., depression).     * Low social support.
  • Protective Factors (Lower Risk): Exercise, education, and greater cognitive engagement.

Frontotemporal Dementia (FTD)

  • Neuropathology: Caused by neuronal death in the frontal and temporal regions of the brain, specifically the prefrontal and anterior temporal cortices.
  • Onset and Progression: Onset typically occurs in the mid-50s50\text{s} and progresses rapidly.
  • Symptom Differentiation: Unlike Alzheimer’s, memory is not usually severely impaired at first.
  • Diagnostic Criteria (Must show impairment in 3 or more):     1. Empathy.     2. Executive function (planning and organization).     3. Ability to inhibit behavior.     4. Compulsive, ritualistic, or perseverative behavior.     5. Hyperorality (placing nonfood objects in the mouth).     6. Apathy.

Vascular Dementia

  • Diagnosis Requirement: This is only diagnosed when vascular disease or injury (such as brain infarction or white matter lesions) results in dementia.
  • Common Cause: Most frequently occurs following a series of strokes.
  • Risk Factors: These are identical to cardiovascular disease risk factors, including smoking, high blood pressure, and high cholesterol.
  • Comorbidity: It can co-occur with Alzheimer’s disease.

Prevention and Treatment of Dementia

  • Current Limitations: There is no cure for any type of dementia, and efficacy of current drugs is limited.
  • Research Focus: Because amyloid plaques and tangles accumulate for years before symptoms appear, research focuses on prevention and studying factors that prevent mild cognitive impairment from developing into full-blown dementia.
  • Medications:     * Cholinesterase inhibitors: Drugs that interfere with the breakdown of acetylcholine to slow cognitive decline. Examples: donepezil (Aricept) and rivastigmine (Exelon). These are often poorly tolerated due to side effects like nausea.     * NMDA antagonists: Memantine (Namenda) affects glutamate receptors involved in memory.     * Secondary Medications: Antidepressants or antipsychotics may be used to treat psychological symptoms (depression, agitation, apathy).
  • Psychological and Lifestyle Treatments:     * Supportive psychotherapy for patients and families: Provides information, emotional expression, and encourages realistic attitudes.     * Exercise: Shows benefit in improving cognitive function in AD patients.     * External memory aids: Using lists and labels to assist memory.     * Engagement in pleasant activities to combat depression.

Delirium

  • Definition: A state of extreme mental confusion and disturbance in attention and awareness.
  • DSM-V Criteria:     * Disturbances in attention and awareness.     * Changes in cognition (orientation, memory, language, perception, or visuospatial ability) not better accounted for by dementia.     * Rapid onset (hours or days) and fluctuation of symptoms throughout the day.     * Evidence that symptoms are caused by a medical condition, substance, or toxin.
  • Clinical Features:     * Fragmented thinking and fragmented sleep/wake cycles.     * Fluctuation between being lucid/coherent and being disoriented (this distinguishes it from Alzheimer's).     * Frequent perceptual disturbances, including visual hallucinations and delusions.     * Severe mood swings.
  • Mortality: If untreated, the mortality rate is high; approximately 13\frac{1}{3} of people with the condition die within a year.
  • Etiology (Causes):     * Drug intoxication or withdrawal.     * Metabolic and nutritional imbalances.     * Infections or fevers.     * Neurological disorders (head trauma, seizures).     * Stress from major injury.
  • Treatment and Prevention:     * Unlike dementia, complete recovery is possible if the underlying cause is treated promptly.     * Atypical antipsychotics are used for confusion and hallucinations.     * Prevention strategies include addressing risk factors like dehydration, sleep deprivation, and proper medication usage.